Long term follow-up of a large patient population with stage 2 and 3 esophageal cancer
Open Access
- 17 July 2020
- journal article
- Published by Peertechz Publications Private Limited in Journal of Surgery and Surgical Research
- Vol. 6 (1), 110-115
- https://doi.org/10.17352/2455-2968.000108
Abstract
Patients with stage II and III esophageal cancer are often incurable with surgery alone, suggesting the importance of optimizing other treatments such as chemotherapy and radiation.Keywords
This publication has 15 references indexed in Scilit:
- Neoadjuvant therapy for advanced esophageal cancer: the impact on surgical managementGeneral Thoracic and Cardiovascular Surgery, 2016
- Multimodality approaches for the curative treatment of esophageal cancer.Journal of the National Comprehensive Cancer Network, 2015
- Role of radiotherapy in the pre-operative management of carcinoma of the esophagusWorld Journal of Gastrointestinal Oncology, 2015
- Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinomaDiagnostic Pathology, 2014
- Preoperative Chemoradiotherapy for Esophageal or Junctional CancerThe New England Journal of Medicine, 2012
- Volume-Outcome Relationship in Surgery for Esophageal malignancy: Systematic Review and Meta-analysis 2000-2011Journal of Gastrointestinal Surgery, 2012
- Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysisThe Lancet Oncology, 2011
- Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancerBritish Journal of Surgery, 2010
- Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781Journal of Clinical Oncology, 2008
- Neoadjuvant chemoradiotherapy for esophageal carcinoma: A meta-analysisSurgery, 2005